| abstract |
The present invention relates to inhibitors of HCV replication of formula (I), the N-oxide forms, the pharmaceutically acceptable addition salts, the quaternary amines and the stereochemically isomeric forms thereof, n nwherein R 1 ; R 3 ; and R 4 have the meaning defined in the claims.n n The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy. |